These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22584714)

  • 1. Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.
    Oberg K
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):109-12. PubMed ID: 22584714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
    Lindholm DP; Oberg K
    Horm Metab Res; 2011 Nov; 43(12):832-7. PubMed ID: 22009449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current knowledge on diagnosis and staging of neuroendocrine tumors.
    Oberg K; Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():3-7. PubMed ID: 21311954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroendocrine neoplasms of the gastrointestinal tract. Classification, clinical presentation and diagnosis].
    Fottner C; Weber MM
    Internist (Berl); 2012 Feb; 53(2):131-44. PubMed ID: 22290317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
    Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies].
    Bergmann F
    Pathologe; 2013 Nov; 34 Suppl 2():221-5. PubMed ID: 24196617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.
    Cimitan M; Buonadonna A; Cannizzaro R; Canzonieri V; Borsatti E; Ruffo R; De Apollonia L
    Ann Oncol; 2003 Jul; 14(7):1135-41. PubMed ID: 12853358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system.
    Ezziddin S; Adler L; Sabet A; Pöppel TD; Grabellus F; Yüce A; Fischer HP; Simon B; Höller T; Biersack HJ; Nagarajah J
    J Nucl Med; 2014 Aug; 55(8):1260-6. PubMed ID: 24876204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chromogranin A measurement in the work-up of neuroendocrine tumors.
    Baudin E; Bidart JM; Bachelot A; Ducreux M; Elias D; Ruffié P; Schlumberger M
    Ann Oncol; 2001; 12 Suppl 2():S79-82. PubMed ID: 11762357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Koffas A; Giakoustidis A; Papaefthymiou A; Bangeas P; Giakoustidis D; Papadopoulos VN; Toumpanakis C
    Front Surg; 2023; 10():1064145. PubMed ID: 36950054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of somatostatin receptor-2 positivitiy in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors.
    Yenıay L; Gürcü B; Ünalp Ö; Yilmaz F; Nart D; Sözbılen M; Çoker A
    Turk J Gastroenterol; 2012; 23(6):736-40. PubMed ID: 23794313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standardization in pathologic diagnosis of gastrointestinal and pancreatic neuroendocrine tumors].
    Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):793-5. PubMed ID: 21215092
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
    Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
    Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin As a Biochemical Marker of Neuroendocrine Tumors.
    Lyubimova NV; Churikova TK; Kushlinskii NE
    Bull Exp Biol Med; 2016 Mar; 160(5):702-4. PubMed ID: 27021085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
    Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
    Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
    Singh S; Law C
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):313-34. PubMed ID: 22646254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic neuroendocrine neoplasms.
    Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.